Anti-proliferation effects of benzimidazole derivatives on HCT-116 colon cancer and MCF-7 breast cancer cell lines

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 4075-4079

  Al Douh, Mohammed Hadi ^a   Sahib, Hayder B ^b   Osman, Hasnah ^c   Hamid, Shafida Abd ^c   Salhimi, Salizawati M ^d  

^a HADHRAMOUT UNIVERSITY   (Yemen)

^b UNIVERSITY OF KERBALA   (Iraq)

^c INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^d SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Anti proliferation; Benzimidazole; Benzyloxy group; Hct 116; Hydroxyl group; Mcf 7; MTT assay

Indexed keywords

EID: 84873664727     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.4075     Document Type: Article

References (38)

1. Al-Douh MH (2010). Synthesis, Characterization and Anti- Proliferation Study of Some Benzimidazole Derivatives. PhD Thesis. Universiti Sains Malaysia (USM), Malaysia, ISNB: 978-3-8443-3294-0, LAP LAMBERT Academic Publishing GmbH & Co. KG, Dudweiler Landstr, 99, 66123 Saarbrücken, Germany.
2. Al-Douh MH, Hamid SA, Osman H, Ng SL, Fun HK (2006). 2-(2-Benzyloxy-3-methoxyphenyl)-1H-benzimidazole. Acta Crystallogr, E, 62, 3954-6.
3. Al-Douh MH, Hamid SA, Osman H (2007). 1D and 2D NMR studies of 2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole. Indo J Chem, 7, 190-6.
4. Al-Douh MH, Osman H, Hamid SA, Kia R, Fun HK (2009a). 2-[1-(2-Hydroxy-3-methoxybenzyl)-1H-benzimidazol-2- yl]-6-methoxyphenol monohydrate. Acta Crystallogr E, 65, 913-4.
5. Al-Douh MH, Osman H, Hamid SA, Kia R, Fun HK (2009b). 2-[1-(2-Hydroxy-3-methoxybenzyl)-1H-benzimidazol- 2-yl]-6-methoxyphenol methanol 1.13-solvate. Acta Crystallogr E, 65, 925-6.
6. Al-Douh MH, Osman H, Hamid SA (2011a). Synthesis and characterization of N-1-(2-hydroxy-3-methoxybenzyl)-2-(2- hydroxy-3-methoxyphenyl)-1H-benzimidazole. Hadh Univ J Nat Appl Sci, 8, 11-32.
7. Al-Douh MH, Osman H, Hamid SA (2011b). Synthesis and characterization of novel benzimidazole: N-1-(2-Benzyloxy- 3-methoxybenzyl)-2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole. Univ Aden J Nat Appl Sci, 15, In Press.
8. Al-Douh MH, Osman H, Hamid SA (2012). Synthesis and characterization of 2-(2-hydroxy-3-methoxyphenyl)-1H-benzimidazole. Hadh Univ J Nat Appl Sci, 9, 49-64.
9. Beaulieu PL, Bousquet Y, Gauthier J, et al. (2004). Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: Inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 Cells. J Med Chem, 47, 6884-92.
10. Cheng J, Xie J, Luo X (2005). Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Bioorg Med Chem Lett, 15, 267-9.
11. Craigo W A, LeSueur B W, Skibo E B (1999). Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents. J Med Chem, 42, 3324-33.
12. Freshney RI (2000). Culture of animal cells: a manual of basic technique. John Wiley & Sons, Inc., New York, USA, 336.
13. Garuti L, Roberti M, Malagoli M, Rossi T, Castelli M (2000). Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives. Bioorg Med Chem Lett, 10, 2193-5.
14. Gudmundsson KS, Tidwell J, Lippa N, et al. (2000). Synthesis and antiviral evaluation of halogenated β-D- and -L-erythrofuranosylbenzimidazoles. J Med Chem, 43, 2464-70.
15. Hong SY, Chung KH, You HJ, et al. (2004). Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation. Bioorg Med Chem Lett, 14, 3563-6.
16. Kazimierczuk Z, Andrzejewska M, Kaustova J, Klimesova V (2005). Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles. Eur J Med Chem, 40, 203-8.
17. Kim JS, Gatto B, Yu C, et al. (1996). Substituted 2,5'-bi-1H-benzimidazoles: Topoisomerase I inhibition and cytotoxicity. J Med Chem, 39, 992-8.
18. Kim JS, Gatto B, Yu C, et al. (1997). Terbenzimidazoles: Influence of 2"-, 4-, and 5-substituents on cytotoxicity and relative potency as Topoisomerase I poisons. J Med Chem, 40, 2818-24.
19. Kopanska (n. Zastapilo) K, Najda A, Zebrowska J, et al. (2004). Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii. Bioorg Med Chem, 12, 2617-24.
20. Kumar D, Jacob MR, Reynolds MB, Kerwin SM (2002). Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1. Bioorg Med Chem, 10, 3997-4004.
21. Kus C, Kilcigil GA, Ozbey S, et al. (2008). Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol- 2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class. Bioorg Med Chem, 16, 4294-303.
22. Li YF, Wang GF, He PL, et al. (2006). Synthesis and anti-Hepatitis B virus activity of novel benzimidazole derivatives. J Med Chem, 49, 4790-4.
23. Mavrova AT, Anichina KK, Vuchev DI, et al. (2005). Synthesis and antitrichinellosis activity of some 2-substituted-[1,3] thiazolo[3,2-a]benzimidazol-3(2H)-ones. Bioorg Med Chem, 13, 5550-9.
24. Mekapati SB, Hansch C (2001). Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting Topoisomerase I. Bioorg Med Chem, 9, 2885-93.
25. Mosmann TJ (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.
26. Nezhad A K, Rad M N S, Mohabatkar H, Asrari Z, Hemmateenejad B (2005). Design, synthesis, antibacterial and QSAR studies of benzimidazole and imidazole chloroaryloxyalkyl derivatives. Bioorg Med Chem, 13, 1931-8.
27. Ozden S, Atabey D, Yildiz S, Goker H (2005). Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg Med Chem, 13, 1587-97.
28. Rangarajan M, Kim J S, Sim S P, et al. (2000). Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles. Bioorg Med Chem, 8, 2591-600.
29. Rida SM, El-Hawash SAM, Fahmy HTY, Hazzaa A A, El-Meligy MMM (2006). Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti-HIV-1, anticancer and antimicrobial activities. Arch Pharm Res, 29, 826-33.
30. Roth T, Morningstar ML, Boyer PL, et al. (1997). Synthesis and biological activity of novel nonnucleoside inhibitors of HIV- 1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. J Med Chem, 40, 4199-207.
31. Smith MBK, Hose BM, Howkins A, et al. (2003). Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: Correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues. J Med Chem, 46, 1940-7.
32. Sondhi SM, Singh N, Kumar A, Lozach O, Meijer L (2006). Synthesis, anti-inflammatory, analgesic and kinase (CDK- 1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff's bases. Bioorg Med Chem, 14, 3758-65.
33. Soto SE, Molina RV, Crespo FA, et al. (2006). Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings Design and synthesis of 5-nitro derivatives. Life Science, 79, 430-5.
34. Starcevic K, Kralj M, Ester K, et al. (2007). Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorg Med Chem, 15, 4419-42.
35. Timmegowda NR, Swamy SN, Kumar CSA, et al. (2008). Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorg Med Chem Lett, 18, 432-5.
36. Townsend LB, Revankav GR (1970). Benzimidazole nucleosides, nucleotides, and related derivatives. Chem Rev, 70, 389-438.
37. Trivedi R, De SK, Gibbs RA (2006). A convenient one-pot synthesis of 2-substituted benzimidazoles. J Mol Catal A Chem, 245, 8-11.
38. Vazquez GN, Vilchis MMR, Mulia LY, et al. (2006). Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres. Eur J Med Chem, 41, 135-41.